Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
14.48
+0.91 (6.71%)
At close: Mar 27, 2026, 4:00 PM EDT
14.75
+0.27 (1.86%)
Pre-market: Mar 30, 2026, 4:33 AM EDT
Vor Biopharma Analyst Ratings
Total Analysts
9
Consensus Rating
Buy
Price Target
$44.13
Upside
+204.77%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Buy Initiates $30 | Buy | Initiates | $30 | +107.18% | Mar 19, 2026 |
| Citigroup | Citigroup | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +245.30% | Jan 9, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $43 → $40 | Buy | Maintains | $43 → $40 | +176.24% | Dec 19, 2025 |
| TD Cowen | TD Cowen | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 17, 2025 |
| JP Morgan | JP Morgan | Buy Initiates $43 | Buy | Initiates | $43 | +196.96% | Dec 9, 2025 |
| Wedbush | Wedbush | Hold Initiates $9 | Hold | Initiates | $9 | -37.85% | Nov 25, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $55 → $32 | Strong Buy | Maintains | $55 → $32 | +120.99% | Nov 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $52 | Strong Buy | Maintains | $3 → $52 | +259.12% | Oct 29, 2025 |
| Baird | Baird | Hold → Buy Upgrades $20 → $64 | Hold → Buy | Upgrades | $20 → $64 | +341.99% | Oct 15, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +314.36% | Aug 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $60 | Hold → Strong Buy | Upgrades | $60 | +314.36% | Jun 30, 2025 |
| Baird | Baird | Hold Maintains $5 → $20 | Hold | Maintains | $5 → $20 | +38.12% | Jun 27, 2025 |
| Wedbush | Wedbush | Hold Reiterates $8 | Hold | Reiterates | $8 | -44.75% | Jun 26, 2025 |
| JMP Securities | JMP Securities | Buy → Hold Downgrades $120 | Buy → Hold | Downgrades | $120 | +728.73% | May 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | May 9, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $160 | Buy | Reiterates | $160 | +1,004.97% | Mar 21, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.